Biohaven Pharmaceuticals, Hospital for Special Care in Patient Trial Testing Treatment for ALS
/A Connecticut-headquartered biopharmaceutical company and a Connecticut hospital are key participants in what is potentially the most comprehensive and promising research effort into finding an effective treatment for amyotrophic lateral sclerosis (ALS) - known as Lou Gehrig’s Disease - which has stubbornly eluded researchers.
Read More